Pathward heads into earnings with shorts elevated and options skewing defensively
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Pathward Financial reports next Tuesday, October 28, and the setup heading into that print is one of the more charged combinations in the regional bank space right now: short interest is high and has risen through the month, options traders have swung sharply toward puts, and the stock is sitting roughly 24% below the analyst consensus target.
Short interest at 12.6% of free float is the clearest structural feature of this setup. That level is elevated for a mid-cap regional bank, and the monthly trend points the wrong way: short positions have grown about 6.8% over the past 30 days, even as they eased slightly in the last week. The borrow market itself offers no obvious squeeze pressure as a counterweight. Availability is generous at around 626%, meaning roughly six shares are available to lend for every two already borrowed. Cost to borrow is near 0.47%, barely above zero in practical terms. Shorts can hold or add positions cheaply, and there is no mechanical pressure forcing them to cover.
The more acute pre-earnings signal is in options. The put/call ratio jumped to 66.4 on Tuesday, well above its 20-day average of 26.5 and near the 52-week high of 77. That puts it about 1.4 standard deviations above the recent mean. Notably, the PCR was above 70 as recently as October 8 and 9, so this is not an isolated spike. Before early October, the ratio was running between 0.8 and 1.4, a more neutral range. The shift toward puts has been abrupt and sustained, and it coincides directly with the period after the last earnings announcement was flagged.
The Street remains constructive, but has been trimming expectations since the July print. After raising targets to $107 and $108 earlier this year, both Piper Sandler and Keefe Bruyette & Woods cut back in late July, following a quarter where the stock dropped 6.2% on results day before recovering most of that over the following week. The consensus mean target stands at $97.50 against a current price near $73.90. That gap looks large, but the most recent analyst activity points in one direction: caution on near-term numbers. The bull case rests on Pathward's revenue-expense discipline, with revenues up close to 6% year-on-year while costs barely moved, and management confidence in the commercial finance pipeline. The bear case is more pressing into this print: loan balances contracted 2% quarter-on-quarter after the transportation portfolio sale, and total deposits hit their smallest Q2 reading on record since 2024, at roughly $5.95 billion, according to FDIC call report data tracked by ORTEX. Net income for the same quarter was similarly the weakest Q2 figure in that dataset.
The FDIC call report data is not yet a measured leading indicator for Pathward's reported figures. ORTEX has flagged that the series has not been tested long enough to confirm a statistical lead relationship. The figures describe the balance sheet of the company's insured bank charters as filed with regulators, not a forecast of the upcoming print. Still, the direction of both series through Q2 is consistent with the bear case concerns the Street has been raising.
Insider activity from the past week is mechanically neutral. On October 16, five executives including the CEO, CFO and President filed tax-withholding transactions (transaction code F) related to equity award vesting. These are compensation mechanics, not discretionary selling, and should be read as such. The 90-day net insider share count rounds to zero when grants and awards are netted out. Institutional holders are broadly stable: BlackRock holds about 14.9% and added modestly in Q3, State Street added 110,000 shares and now holds 6.9%, and American Century increased its stake to over 6%. The Vanguard Group reduced to below the 5% threshold in March and has not filed a further update, consistent with the 13D/G disclosure rules.
The ORTEX short score for the stock is 66.6, placing it in roughly the 98th percentile of its universe by that measure, a reading that has held steady near this level for the past two weeks. What to watch into October 28 is whether loan growth guidance and deposit trajectory commentary shift the bear-side narrative, or whether the operating leverage story is enough to close the gap between where the stock trades and where analysts have been anchoring their targets.
Stocks in this article
See the live data behind this article on ORTEX.
Open CASH on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 22:22
- Data as of
- 21 Oct 2026, 22:22
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.